Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03160716 · ClinicalTrials.gov registry record · NA
Injection Technique Assessment of Restylane Lyft With Lidocaine for Cheek Augmentation
A NA study of Cheek Augmentation and Midface Contour Deficiencies, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 4
- Study locations
NCT03160716: Completed NA study of Cheek Augmentation and Midface Contour Deficiencies, sponsored by Galderma R&D.
NCT03160716 is a NA study of Cheek Augmentation and Midface Contour Deficiencies that has completed, run by Galderma R&D. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03160716, a NA study of Cheek Augmentation and Midface Contour Deficiencies, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a multi-center, open-label, single-arm study to evaluate an injection tool with Restylane Lyft with Lidocaine for cheek augmentation and correction of age related midface contour deficiencies.
Primary Outcome
To assess the adverse events (incidence, intensity, and duration) of Restylane® Lyft with Lidocaine in conjunction with the use of a cannula.
Conditions Studied
Interventions
- DEVICE Restylane Lyft with Lidocaine
Study Locations (4)
California
- Facial Plastic and Cosmetic Surgery - Beverly Hills
- Skin Care and Laser Physicians of Beverly Hills - Los Angeles
- Hessler Plastic Surgery - Palo Alto
New York
- Union Square Laser Dermatology - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-05-16 |
| Est. Completion | 2017-10-31 |
| Phase | NA |
What the finished NCT03160716 record still lists
NCT03160716 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Cheek Augmentation appearing as the primary indexed condition, and to 1 intervention - of which Restylane Lyft with Lidocaine is the first listed.
NCT03160716 reports a single indexed study location in California, New York.
Frequently Asked Questions
What is clinical trial NCT03160716 about?
NCT03160716 is a clinical study titled "Injection Technique Assessment of Restylane Lyft With Lidocaine for Cheek Augmentation". This is a multi-center, open-label, single-arm study to evaluate an injection tool with Restylane Lyft with Lidocaine for cheek augmentation and correction of age related midface contour deficiencies.
What is the current status of trial NCT03160716?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-05-16. Estimated completion is 2017-10-31.
What conditions does trial NCT03160716 study?
This clinical trial studies the following conditions: Cheek Augmentation, Midface Contour Deficiencies.
What interventions are being tested in trial NCT03160716?
The interventions under investigation include: Restylane Lyft with Lidocaine (DEVICE).
Who is sponsoring clinical trial NCT03160716?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03160716 being conducted?
This trial has 4 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03160716's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI